Cargando…
Clematichinenoside (AR) Attenuates Hypoxia/Reoxygenation-Induced H9c2 Cardiomyocyte Apoptosis via a Mitochondria-Mediated Signaling Pathway
Mitochondria-mediated cardiomyocyte apoptosis is involved in myocardial ischemia/reperfusion (MI/R) injury. Clematichinenoside (AR) is a triterpenoid saponin isolated from the roots of Clematis chinensis with antioxidant and anti-inflammatory cardioprotection effects against MI/R injury, yet the ant...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273438/ https://www.ncbi.nlm.nih.gov/pubmed/27248986 http://dx.doi.org/10.3390/molecules21060683 |
_version_ | 1783377384566685696 |
---|---|
author | Ding, Haiyan Han, Rong Chen, Xueshan Fang, Weirong Liu, Meng Wang, Xuemei Wei, Qin Kodithuwakku, Nandani Darshika Li, Yunman |
author_facet | Ding, Haiyan Han, Rong Chen, Xueshan Fang, Weirong Liu, Meng Wang, Xuemei Wei, Qin Kodithuwakku, Nandani Darshika Li, Yunman |
author_sort | Ding, Haiyan |
collection | PubMed |
description | Mitochondria-mediated cardiomyocyte apoptosis is involved in myocardial ischemia/reperfusion (MI/R) injury. Clematichinenoside (AR) is a triterpenoid saponin isolated from the roots of Clematis chinensis with antioxidant and anti-inflammatory cardioprotection effects against MI/R injury, yet the anti-apoptotic effect and underlying mechanisms of AR in MI/R injury remain unclear. We hypothesize that AR may improve mitochondrial function to inhibit MI/R-induced cardiomyocyte apoptosis. In this study, we replicated an in vitro H9c2 cardiomyocyte MI/R model by hypoxia/reoxygenation (H/R) treatment. The viability of H9c2 cardiomyocytes was determined by MTT assay; apoptosis was evaluated by flow cytometry and TUNEL experiments; mitochondrial permeability transition pore (mPTP) opening was analyzed by a calcein-cobalt quenching method; and mitochondrial membrane potential (ΔΨm) was detected by JC-1. Moreover, we used western blots to determine the mitochondrial cytochrome c translocation to cytosolic and the expression of caspase-3, Bcl-2, and Bax proteins. These results showed that the application of AR decreased the ratio of apoptosis and the extent of mPTP opening, but increased ΔΨm. AR also inhibited H/R-induced release of mitochondrial cytochrome c and decreased the expression of the caspase-3, Bax proteins. Conversely, it remarkably increased the expression of Bcl-2 protein. Taken together, these results revealed that AR protects H9c2 cardiomyocytes against H/R-induced apoptosis through mitochondrial-mediated apoptotic signaling pathway. |
format | Online Article Text |
id | pubmed-6273438 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62734382018-12-28 Clematichinenoside (AR) Attenuates Hypoxia/Reoxygenation-Induced H9c2 Cardiomyocyte Apoptosis via a Mitochondria-Mediated Signaling Pathway Ding, Haiyan Han, Rong Chen, Xueshan Fang, Weirong Liu, Meng Wang, Xuemei Wei, Qin Kodithuwakku, Nandani Darshika Li, Yunman Molecules Article Mitochondria-mediated cardiomyocyte apoptosis is involved in myocardial ischemia/reperfusion (MI/R) injury. Clematichinenoside (AR) is a triterpenoid saponin isolated from the roots of Clematis chinensis with antioxidant and anti-inflammatory cardioprotection effects against MI/R injury, yet the anti-apoptotic effect and underlying mechanisms of AR in MI/R injury remain unclear. We hypothesize that AR may improve mitochondrial function to inhibit MI/R-induced cardiomyocyte apoptosis. In this study, we replicated an in vitro H9c2 cardiomyocyte MI/R model by hypoxia/reoxygenation (H/R) treatment. The viability of H9c2 cardiomyocytes was determined by MTT assay; apoptosis was evaluated by flow cytometry and TUNEL experiments; mitochondrial permeability transition pore (mPTP) opening was analyzed by a calcein-cobalt quenching method; and mitochondrial membrane potential (ΔΨm) was detected by JC-1. Moreover, we used western blots to determine the mitochondrial cytochrome c translocation to cytosolic and the expression of caspase-3, Bcl-2, and Bax proteins. These results showed that the application of AR decreased the ratio of apoptosis and the extent of mPTP opening, but increased ΔΨm. AR also inhibited H/R-induced release of mitochondrial cytochrome c and decreased the expression of the caspase-3, Bax proteins. Conversely, it remarkably increased the expression of Bcl-2 protein. Taken together, these results revealed that AR protects H9c2 cardiomyocytes against H/R-induced apoptosis through mitochondrial-mediated apoptotic signaling pathway. MDPI 2016-05-30 /pmc/articles/PMC6273438/ /pubmed/27248986 http://dx.doi.org/10.3390/molecules21060683 Text en © 2016 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ding, Haiyan Han, Rong Chen, Xueshan Fang, Weirong Liu, Meng Wang, Xuemei Wei, Qin Kodithuwakku, Nandani Darshika Li, Yunman Clematichinenoside (AR) Attenuates Hypoxia/Reoxygenation-Induced H9c2 Cardiomyocyte Apoptosis via a Mitochondria-Mediated Signaling Pathway |
title | Clematichinenoside (AR) Attenuates Hypoxia/Reoxygenation-Induced H9c2 Cardiomyocyte Apoptosis via a Mitochondria-Mediated Signaling Pathway |
title_full | Clematichinenoside (AR) Attenuates Hypoxia/Reoxygenation-Induced H9c2 Cardiomyocyte Apoptosis via a Mitochondria-Mediated Signaling Pathway |
title_fullStr | Clematichinenoside (AR) Attenuates Hypoxia/Reoxygenation-Induced H9c2 Cardiomyocyte Apoptosis via a Mitochondria-Mediated Signaling Pathway |
title_full_unstemmed | Clematichinenoside (AR) Attenuates Hypoxia/Reoxygenation-Induced H9c2 Cardiomyocyte Apoptosis via a Mitochondria-Mediated Signaling Pathway |
title_short | Clematichinenoside (AR) Attenuates Hypoxia/Reoxygenation-Induced H9c2 Cardiomyocyte Apoptosis via a Mitochondria-Mediated Signaling Pathway |
title_sort | clematichinenoside (ar) attenuates hypoxia/reoxygenation-induced h9c2 cardiomyocyte apoptosis via a mitochondria-mediated signaling pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273438/ https://www.ncbi.nlm.nih.gov/pubmed/27248986 http://dx.doi.org/10.3390/molecules21060683 |
work_keys_str_mv | AT dinghaiyan clematichinenosidearattenuateshypoxiareoxygenationinducedh9c2cardiomyocyteapoptosisviaamitochondriamediatedsignalingpathway AT hanrong clematichinenosidearattenuateshypoxiareoxygenationinducedh9c2cardiomyocyteapoptosisviaamitochondriamediatedsignalingpathway AT chenxueshan clematichinenosidearattenuateshypoxiareoxygenationinducedh9c2cardiomyocyteapoptosisviaamitochondriamediatedsignalingpathway AT fangweirong clematichinenosidearattenuateshypoxiareoxygenationinducedh9c2cardiomyocyteapoptosisviaamitochondriamediatedsignalingpathway AT liumeng clematichinenosidearattenuateshypoxiareoxygenationinducedh9c2cardiomyocyteapoptosisviaamitochondriamediatedsignalingpathway AT wangxuemei clematichinenosidearattenuateshypoxiareoxygenationinducedh9c2cardiomyocyteapoptosisviaamitochondriamediatedsignalingpathway AT weiqin clematichinenosidearattenuateshypoxiareoxygenationinducedh9c2cardiomyocyteapoptosisviaamitochondriamediatedsignalingpathway AT kodithuwakkunandanidarshika clematichinenosidearattenuateshypoxiareoxygenationinducedh9c2cardiomyocyteapoptosisviaamitochondriamediatedsignalingpathway AT liyunman clematichinenosidearattenuateshypoxiareoxygenationinducedh9c2cardiomyocyteapoptosisviaamitochondriamediatedsignalingpathway |